LZTS2 antibody

Synonyms:KIAA1813 antibody, LAPSER1 antibody
Catalogue No.:FNab04918Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, IHC, WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
LZTS2 antibody
Catalogue No.
FNab04918
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
leucine zipper, putative tumor suppressor 2
Alternative Names
KIAA1813 antibody, LAPSER1 antibody
UniProt ID
Q9BRK4
Observed MW
70-80 kDa
Application
Tested Applications
ELISA, IHC, WB
Recommended dilution
WB: 1:500-1:2000; IHC: 1:20-1:200
Validated Images
PC-3 cells were subjected to SDS PAGE followed by western blot with FNab04918(LZTS2 Antibody) at dilution of 1:300
Immunohistochemistry of paraffin-embedded human prostate hyperplasia tissue slide using FNab04918(LZTS2 Antibody) at dilution of 1:50
Background
Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.